Document Detail


Sympathetic (alpha-beta) or calcium channel blockade for hypertensive myocardial infarction? A haemodynamic comparison of labetalol and nifedipine.
MedLine Citation:
PMID:  2906956     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The haemodynamic impact of alpha- and beta-adrenoceptor blockade (labetalol) was compared with that of slow-calcium channel blockade (nifedipine) in 32 patients with sustained elevation of systemic arterial pressure (systolic blood pressure greater than 160; diastolic blood pressure greater than 95 mmHg) following a recent myocardial infarction (6-22 h). Patients with normal (pulmonary artery occluded pressure; (PAOP less than 18 mmHg; n = 16) or impaired (PAOP greater than 18 mmHg; n = 16) left ventricular function were randomized to labetalol (1 mg/kg i.v. 15 min) or nifedipine (20 mg sublingually) and haemodynamic profile was measured over 2 h. Both drugs equally reduced mean systemic arterial pressure (P less than 0.01 versus pretreatment control), and presumably left ventricular afterload; however, the heart rate (P less than 0.01) and cardiac index (P less than 0.01) increased after nifedipine, contrasting with reductions in both variables following labetalol (P less than 0.01). The elevated left ventricular filling pressure was reduced by both labetalol (P less than 0.05) and nifedipine (P less than 0.01) but the reduction was greater following nifedipine (-2 mmHg versus -5 mmHg, P less than 0.05). Thus both compounds were equally effective hypotensive agents. Labetalol consistently reduced cardiac stroke work and double product, important determinants of myocardial oxygen requirements; however, nifedipine afforded some improvement in cardiac performance in patients with left ventricular dysfunction.
Authors:
S P Verma; B Silke; M Hussain; G I Nelson; J A Wilson; G W Reynolds; A Richmond; S H Taylor
Related Documents :
3006466 - Adrenergic activity and left ventricular function during treatment of essential hyperte...
2893636 - Comparison of ketanserin and slow-release nifedipine added to the treatment of hyperten...
8453956 - Comparative effects of felodipine, nitrendipine and nifedipine in healthy subjects: con...
7534496 - Contrasting short-term effects of nifedipine on glomerular and tubular functions in glo...
8803516 - Dose-finding study of imidapril, a novel angiotensin converting enzyme inhibitor, in pa...
712196 - Temporal relationships between urinary salt retention and altered systemic hemodynamics...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of hypertension     Volume:  6     ISSN:  0263-6352     ISO Abbreviation:  J. Hypertens.     Publication Date:  1988 Nov 
Date Detail:
Created Date:  1989-05-01     Completed Date:  1989-05-01     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  897-904     Citation Subset:  IM    
Affiliation:
University Department of Cardiovascular Studies, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Antagonists / therapeutic use
Adrenergic beta-Antagonists / therapeutic use
Adult
Aged
Calcium Channel Blockers / therapeutic use
Hemodynamics / drug effects
Humans
Hypertension / drug therapy*,  physiopathology
Labetalol / therapeutic use*
Male
Middle Aged
Myocardial Infarction / drug therapy*,  physiopathology
Nifedipine / therapeutic use*
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Antagonists; 0/Adrenergic beta-Antagonists; 0/Calcium Channel Blockers; 21829-25-4/Nifedipine; 36894-69-6/Labetalol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lithium and renal function in relation to concomitant theory.
Next Document:  Mlsa determinants: relationship to Fc gamma receptor and tissue distribution.